Literature DB >> 30915646

Neuroblastoma in a Developing Country: Miles to Go.

Jagdish Prasad Meena1, Aditya Kumar Gupta2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30915646     DOI： 10.1007/s12098-019-02930-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  15 in total

1.  Urine catecholamines in paediatrics.

Authors:  Daniel J Erdelyi; Martin Elliott; Bob Phillips
Journal:  Arch Dis Child Educ Pract Ed       Date:  2011-06       Impact factor: 1.309

2.  Real World Experience of Treating Neuroblastoma: Experience from a Tertiary Cancer Centre in India.

Authors:  Venkatraman Radhakrishnan; Anand Raja; Manikandan Dhanushkodi; T S Ganesan; G Selvaluxmy; T G Sagar
Journal:  Indian J Pediatr       Date:  2019-02-18       Impact factor: 1.967

Review 3.  Neuroblastoma: biology, prognosis, and treatment.

Authors:  Julie R Park; Angelika Eggert; Huib Caron
Journal:  Hematol Oncol Clin North Am       Date:  2010-02       Impact factor: 3.722

4.  Neuroblastoma in southern Africa: epidemiological features, prognostic factors and outcome.

Authors:  P B Hesseling; K Ankone; G Wessels; J W Schneider; L Du Plessis; S Moore
Journal:  Ann Trop Paediatr       Date:  1999-12

5.  Clinico-pathologic characteristics and treatment outcomes in children with neuroblastoma at the Kenyatta National Hospital, Nairobi.

Authors:  G W Kitonyi; W M Macharia; O W Mwanda; R Pamnani
Journal:  East Afr Med J       Date:  2009-12

6.  Neuroblastoma: outcome over a 14 year period from a tertiary care referral centre in India.

Authors:  Sandeep Agarwala; Ankur Mandelia; Sameer Bakhshi; M Srinivas; Minu Bajpai; Arun K Gupta; Devendra K Gupta; Veereshwar Bhatnagar
Journal:  J Pediatr Surg       Date:  2014-06-30       Impact factor: 2.545

7.  Neuroblastoma in southern Brazil: an 11-year study.

Authors:  Ivy Zortéa S Parise; Bassem R Haddad; Luciane R Cavalli; Mara A D Pianovski; Ewerton M Maggio; Guilherme A Parise; Flora M Watanabe; Sérgio O Ioshii; Janice D Rone; Luiz Gonzaga Caleffe; Vicente Odone Filho; Bonald C Figueiredo
Journal:  J Pediatr Hematol Oncol       Date:  2006-02       Impact factor: 1.289

8.  Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.

Authors:  Katherine K Matthay; Veronique Edeline; Jean Lumbroso; Marie Laure Tanguy; Bernard Asselain; Jean Michel Zucker; Dominique Valteau-Couanet; Olivier Hartmann; Jean Michon
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

9.  Profile and outcome of neuroblastoma with convertional chemotherapy in children older than one year: a 15-years experience.

Authors:  Deepak Bansal; R K Marwaha; Amita Trehan; K L N Rao; Vishal Gupta
Journal:  Indian Pediatr       Date:  2008-02       Impact factor: 1.411

10.  SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings.

Authors:  Nehal S Parikh; Scott C Howard; Guillermo Chantada; Trijn Israels; Mohammed Khattab; Patricia Alcasabas; Catherine G Lam; Lawrence Faulkner; Julie R Park; Wendy B London; Katherine K Matthay
Journal:  Pediatr Blood Cancer       Date:  2015-03-21       Impact factor: 3.167
View more
  2 in total

1.  Nomogram for predicting overall survival in children with neuroblastoma based on SEER database.

Authors:  Song-Wu Liang; Gang Chen; Yi-Ge Luo; Peng Chen; Jin-Han Gu; Qiong-Qian Xu; Yi-Wu Dang; Li-Ting Qin; Hui-Ping Lu; Wen-Ting Huang; Zhi-Guang Huang; Li Gao; Jia-Bo Chen
Journal:  Ann Surg Treat Res       Date:  2020-07-31       Impact factor: 1.859

2.  LIN28A gene polymorphisms modify neuroblastoma susceptibility: A four-centre case-control study.

Authors:  Rui-Xi Hua; Zhenjian Zhuo; Lili Ge; Jinhong Zhu; Li Yuan; Chongfen Chen; Jing Liu; Jiwen Cheng; Haixia Zhou; Jiao Zhang; Huimin Xia; Xianwei Zhang; Jing He
Journal:  J Cell Mol Med       Date:  2019-11-20       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.